Stock listing

GMAB Stock Price, News, Filings & Events — Genmab A/s

Selected listing: GMAB · OMXCOP · DKK · DK

This page tracks Genmab A/s's GMAB:OMXCOP listing on OMXCOP in DKK for DK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GMAB:OMXCOP. GMAB:OMXCOP is the stock-level entry point for investors researching Genmab A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genmab A/S is a public company listed on the Danish stock market under the ticker GMAB. The company has a market capitalization of approximately 17.26 billion USD. Genmab focuses on developing innovative antibody therapies for the treatment of cancer and other diseases.

GMAB:OMXCOPDKKDKUpdated September 12, 2026
Genmab A/s logo
Ticker
GMAB:OMXCOP
Asset type
Stock
Market cap
$19.28B
Sector
Health Technology
Industry
Biotechnology
Exchange
OMXCOP
Currency
DKK

Genmab A/s GMAB:OMXCOP stock context

This page tracks Genmab A/s's GMAB:OMXCOP listing on OMXCOP in DKK for DK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GMAB:OMXCOP. GMAB:OMXCOP is the stock-level entry point for investors researching Genmab A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genmab A/S is a public company listed on the Danish stock market under the ticker GMAB. The company has a market capitalization of approximately 17.26 billion USD. Genmab focuses on developing innovative antibody therapies for the treatment of cancer and other diseases.

Latest news from Genmab A/s

All Genmab A/s news →

Genmab A/s earnings calls

Research Genmab A/s

Alternate listings